During the past decade, Regional Epilepsy Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Regional Epilepsy Center" are "Epilepsy" (2 trials) and "Refractory Partial Seizures" (1 trials). Many other conditions were trialed in "Regional Epilepsy Center" in a lesser frequency.

Most popular intervention types in "Regional Epilepsy Center" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "E2007 (perampanel)" (1 trials), "Eslicarbazepine acetate" (1 trials), "Eslicarbazepine acetate 1200 mg" (1 trials), "Eslicarbazepine acetate 1600 mg" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Regional Epilepsy Center" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Regional Epilepsy Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Regional Epilepsy Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Regional Epilepsy Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".